Pfizer Reached a Drug Price Deal With the Trump Administration

The U.S. government and Pfizer made a deal about drug prices.

Pfizer agreed to lower prices on some drugs, especially for people with low incomes through Medicaid, and to sell some drugs at prices similar to those in other wealthy countries.

In return, the company won't face tariffs on some of its products.

This deal helps President Trump announce lower prices and avoid tariffs.

Some other drug company leaders are concerned by the deal and how the government is involved.

The deal only has a limited impact on Pfizer's profits.